Emflaza

Deflazacort

Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients at the age of 5 and older.
more
Package Per pill Price Savings Order
180 tablet
A$ 1.13
A$ 202.77A$ 1.13
A$ 358.50
120 tablet
A$ 1.30
A$ 155.96A$ 1.30
A$ 218.22
90 tablet
A$ 1.56
A$ 140.36A$ 1.56
A$ 140.28
60 tablet
A$ 1.95
A$ 116.95A$ 1.95
A$ 70.14
30 tablet
A$ 3.12
A$ 93.55A$ 3.12
Package Per pill Price Savings Order
120 tablet
Free AirMail shipping Hot
A$ 7.15
A$ 858.14A$ 7.15
A$ 155.73
90 tablet
Free AirMail shipping Hot
A$ 7.54
A$ 678.70A$ 7.54
A$ 81.71
60 tablet
Free AirMail shipping Hot
A$ 7.80
A$ 468.04A$ 7.80
A$ 38.89
36 tablet
Free AirMail shipping Hot
A$ 8.23
A$ 296.40A$ 8.23
A$ 7.76
24 tablet
A$ 8.45
A$ 202.77A$ 8.45
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
A$ 8.67
A$ 780.12A$ 8.67
A$ 155.83
60 tablet
Free AirMail shipping Hot
A$ 9.36
A$ 561.67A$ 9.36
A$ 62.30
36 tablet
Free AirMail shipping Hot
A$ 9.97
A$ 358.81A$ 9.97
A$ 15.56
24 tablet
Free AirMail shipping Hot
A$ 10.40
A$ 249.59A$ 10.40
Emflaza

Brand(s)

Manufacturer

  • Lupin

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.